Moonkind
Survivors of Ebola
by Bruce Merchant
This title was previously available on NetGalley and is now archived.
Buy on Amazon
Buy on BN.com
Buy on Bookshop.org
*This page contains affiliate links, so we may earn a small commission when you make a purchase through links on our site at no additional cost to you.
Send NetGalley books directly to your Kindle or Kindle app
1
To read on a Kindle or Kindle app, please add kindle@netgalley.com as an approved email address to receive files in your Amazon account. Click here for step-by-step instructions.
2
Also find your Kindle email address within your Amazon account, and enter it here.
Pub Date Apr 17 2015 | Archive Date Jul 03 2015
Smith Publicity | lulu
Description
In another century and a half, the world, as we know it, will be greatly changed. This book foresees changes that most of us could scarcely dream of. But several earthly problems have not been resolved. One of these is the periodic emergence of infectious diseases that have evaded all efforts to prevent or control them. Enter Q-strain, an astoundingly pernicious mutation of Ebola virus which totally wipes out all humans on the Earth. There is time, however, to transport the very earliest stage of clones to the robotic station on the Moon. When the "all clear" for absence of the Ebola Q-strain mutant on the Earth has been biologically verified, these clones are given birth on the Moon and raised to adulthood by robotic guides and caretakers. The story then centers on the development of fourteen clones who must return a human presence to our now Ebola-free blue planet. This sounds like quite a challenge, and in fact, that's just what it is.
A Note From the Publisher
Author is available for interviews, blog tours, autographed book giveaways, contests, and book club discussions.
Author is available for interviews, blog tours, autographed book giveaways, contests, and book club discussions.
Advance Praise
An Extraordinary and Unputdownable ReadBy TAHIR SHAH on May 15, 2015Format: Kindle EditionMOONKIND is one of the most profound works of science fiction I have ever read. I recommend this book very very highly. It will change the way you think about humanity and indeed life itself.
Marketing Plan
Author Bio:
Bruce Merchant, M.D., is a Research Physician in the Immunology and Pathology of Human responses to tumors and infectious diseases.. Bruce also holds a doctorate in Immunopathology from the University of Chicago. He was a lab researcher at the National Institutes of Health for a decade and then continued his research in Immunology, and Immunogenetics at the FDA for a second decade. He then moved mainly into Clinical Research and served first as the Director of Clinical studies at Hybritech, Inc. and later as Clinical V.P at Viagene, Inc. both Biotech companies in San Diego, California.
He then teamed up with James A. Taylor, Ph. D, to whom this book is dedicated. Together, they formed Merchant-Taylor International, Inc. (MTI), a consulting firm that over the past two decades has assisted over 200 Biotech and Small Pharma companies in moving their products forward through successive phases of Clinical Development.
Bruce still works full time in this consulting capacity. Many of MTI's clients are developing therapies aimed at controlling infections or malignant tumors, and Bruce serves as the Clinical Monitor for several of these studies. He is also involved with two separate Clinical Studies, one which involves the use of Convalescent Immune Plasma (from Ebola survivors) and another employing a number of promising new pharmaceuticals which will be critically tested in Ebola patients in West Africa in an effort to control the current deadly epidemic.
Bruce Merchant, M.D., is a Research Physician in the Immunology and Pathology of Human responses to tumors and infectious diseases.. Bruce also holds a doctorate in Immunopathology from the University of Chicago. He was a lab researcher at the National Institutes of Health for a decade and then continued his research in Immunology, and Immunogenetics at the FDA for a second decade. He then moved mainly into Clinical Research and served first as the Director of Clinical studies at Hybritech, Inc. and later as Clinical V.P at Viagene, Inc. both Biotech companies in San Diego, California.
He then teamed up with James A. Taylor, Ph. D, to whom this book is dedicated. Together, they formed Merchant-Taylor International, Inc. (MTI), a consulting firm that over the past two decades has assisted over 200 Biotech and Small Pharma companies in moving their products forward through successive phases of Clinical Development.
Bruce still works full time in this consulting capacity. Many of MTI's clients are developing therapies aimed at controlling infections or malignant tumors, and Bruce serves as the Clinical Monitor for several of these studies. He is also involved with two separate Clinical Studies, one which involves the use of Convalescent Immune Plasma (from Ebola survivors) and another employing a number of promising new pharmaceuticals which will be critically tested in Ebola patients in West Africa in an effort to control the current deadly epidemic.
Available Editions
| EDITION | Paperback |
| ISBN | 9781312873988 |
| PRICE | $24.99 (USD) |
Links
Average rating from 11 members
Readers who liked this book also liked:
